Meling D
Psychedelic Research and Therapy Development, Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich and University of Zurich, Zurich, Switzerland.
ArticleAyahuasca
Mixed-methods analysis on psychedelic-augmented meditation experiences from a randomized controlled mindfulness retreat.
ArticlePsilocybin
Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of <i>N,N</i>-dimethyltryptamine and harmine in a meditation retreat.
PreprintPsilocybin
Meditation, Psychedelics, and Brain Connectivity: A Randomised Controlled Resting-State fMRI Study of <i>N,N</i>-Dimethyltryptamine and Harmine in a Meditation Retreat
ArticleAyahuasca
Enhancing mindfulness and compassion through an ayahuasca-inspired formulation containing N,N-DMT and harmine: A randomized controlled trial in healthy subjects.
ArticleAyahuasca
Ayahuasca-inspired DMT/HAR formulation reduces brain differentiation between self and other faces.
ArticleAyahuasca
Examining the pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and harmine in healthy volunteers: Α factorial dose-escalation study.
ArticleAyahuasca
Pharmacokinetics and pharmacodynamics of an innovative psychedelic N,N-dimethyltryptamine/harmine formulation in healthy participants: a randomized controlled trial.
PreprintAyahuasca
Ayahuasca-Inspired DMT/HAR Formulation Reduces Brain Differentiation Between Self and Other Faces
ArticleDMT
Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat.
ArticlePsilocybin
Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation.
ArticleAyahuasca
Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects.
ArticlePsychedelics